Liver-directed (LD) Therapy for Intermediate Stage Hepatocellular Carcinoma: Survival Across Treatment Strategies

被引：0
|
作者：
Castillo, Alvaro E. [1 ]
Naugler, Willscott E. [2 ]
Kolbeck, Kenneth J. [3 ]
Farsad, Khashayar [3 ]
Orloff, Susan L. [1 ]
Billingsley, Kevin [4 ]
Enestvedt, C. Kristian [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Surg, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Internal Med, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Dotter Intervent Inst, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Div Surg Oncol, Portland, OR 97201 USA
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
481
引用
收藏
页码：451A / 452A
页数：2
相关论文
共 50 条
  • [31] Liver Transplantation for Intermediate-Stage Hepatocellular Carcinoma
    Kamo, Naoko
    Kaido, Toshimi
    Yagi, Shintaro
    Okajima, Hideaki
    Uemoto, Shinji
    LIVER CANCER, 2018, 7 (02) : 179 - 189
  • [32] Liver-Directed Regional Therapy in the Multi-Disciplinary Management of Hepatocellular Cancer
    Senthil, Maheswari
    Mailey, Brian
    Leong, Lucille
    Chung, Vincent
    Yen, Yun
    Chen, Yi-Jen
    Marx, Howard
    Kim, Joseph
    CURRENT CANCER THERAPY REVIEWS, 2010, 6 (01) : 19 - 25
  • [33] Role of liver-directed local tumor therapy in the management of hepatocellular carcinoma with extrahepatic metastases: a SEER database analysis
    Abdel-Rahman, Omar
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (02) : 183 - 189
  • [34] New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
    Kudo, Masatoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1110 - 1119
  • [35] New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
    Masatoshi Kudo
    International Journal of Clinical Oncology, 2022, 27 : 1110 - 1119
  • [36] Impact of hepatic function and tumor extent on survival in patients with unresectable hepatocellular carcinoma treated with liver-directed therapies.
    Hill, Marisa E.
    Basu, Sanjib
    Arslan, Bulent
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [37] Biomarkers for Locally Advanced Hepatocellular Carcinoma Patients Treated with Liver-Directed Combined Radiotherapy
    Chung, Seung Yeun
    Kim, Kyoung-Jin
    Seong, Jinsil
    LIVER CANCER, 2022, 11 (03) : 247 - 255
  • [38] Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma
    Niekamp, Andrew
    Abdel-Wahab, Reham
    Kuban, Joshua
    Odisio, Bruno C.
    Mahvash, Armeen
    Hassan, Manal M.
    Qayyum, Aliya
    Kaseb, Ahmed
    Sheth, Rahul A.
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (04):
  • [39] TRANSARTERIAL CHEMOEMBOLIZATION IN THE INTERMEDIATE STAGE OF HEPATOCELLULAR CARCINOMA: SURVIVAL ANALYSIS
    Tajibaev, T. K.
    Medeubekov, U. Sh
    Chormanov, A. T.
    Sagatov, I. Y.
    Kaniev, Sh A.
    Issamatov, B. K.
    Baimakhanov, B. B.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (02): : 111 - 114
  • [40] Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma
    Chen, Shuling
    Jin, Huilin
    Dai, Zihao
    Wei, Mengchao
    Xiao, Han
    Su, Tianhong
    Li, Bin
    Liu, Xin
    Wang, Yu
    Li, Jiaping
    Shen, Shunli
    Zhou, Qi
    Peng, Baogang
    Peng, Zhenwei
    Peng, Sui
    CANCER MEDICINE, 2019, 8 (04): : 1530 - 1539
12345